The Conclusion of the 2nd HiLo-Trial DSMB review: Continue the Trial
The Data Safety Monitoring Board (DSMB) reviewed the data after 400 patients were enrolled at least 28 days old, to assess the safety of...
Oct 2, 20232 min read
top of page
Recent Posts
Archive
bottom of page